教員別検索 - 山口　隆志

専門領域

所属学会等

学術雑誌掲載論文

学会発表

研究の専門分野

医療上の専門領域

（最終更新日：2025-11-07 11:57:53）

  ヤマグチ　タカシ   YAMAGUCHI TAKASHI
  山口　隆志
   所属   内科学第三講座

職種講師

■ 専門領域

内科

■ 所属学会等

1.	2002/08	日本内科学会
	2012	∟ 内科認定医
2.	2003/06～	日本肝臓学会
	2012	∟ 肝臓専門医
3.	2003/06～	日本消化会病学会
	2013	∟ 消化器病専門医
4.	2003/06～	日本消化器内視鏡学会
	2013	∟ 消化器内視鏡専門医
5件表示
全件表示(8件)

■ 学術雑誌掲載論文

1.	原著(症例報告除く)	Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy 2025/03
2.	原著(症例報告除く)	Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib 2024/07
3.	原著(症例報告除く)	The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy 2023/05
4.	原著(症例報告除く)	Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy 2022/10
5.	総説	Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis 2022/06
6.	原著(症例報告除く)	Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases 2022/03
7.	原著(症例報告除く)	Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients 2021/12
8.	原著(症例報告除く)	Possible Involvement of Innate Lymphoid Cells in the Development of Chronic Inflammatory Pancreatic Diseases 2020/11
9.	原著(症例報告除く)	Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis 2020/08
10.	原著(症例報告除く)	Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas 2020/06
11.	原著(症例報告除く)	Extracellular vesicles microRNA analysis in type 1 autoimmune pancreatitis: Increased expression of microRNA-21 2020/04
12.	原著(症例報告除く)	Clinical implications of elevated serum interleukin-6 in IgG4-related disease. 2020/01
13.	原著(症例報告除く)	Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas. 2020/01
14.	原著(症例報告除く)	Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis. 2020/01
15.	その他	Endoscopic surveillance and BRTO for gastric varices (Examination from the ruptured cases) 2019/12
16.	原著(症例報告除く)	Short term treatment results of local ablation with water-cooled microwave antenna for liver cancer: Comparison with radiofrequency ablation 2019/12
17.	原著(症例報告除く)	Acute necrotizing pancreatitis as a fatal complication following DC Bead transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and review of the literature. 2018/10
18.	原著(症例報告除く)	Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis. 2018/06
19.	症例報告	S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report 2016/12
20.	その他	【肝硬変を理解する-分子機構から実臨床に至るまで-】原因別にみた病態と進展の特徴　硬化性胆管炎に伴う肝硬変 2016/12
21.	総説	Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions 2016/01
22.	症例報告	Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report 2015/04
23.	原著(症例報告除く)	EOB-MRI肝細胞相で高信号を呈する結節性再生性過形成様の多発結節を認めた特発性門脈圧亢進症の一例 2014/11
24.	総説	TGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review) 2014/10
25.	総説	Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases. 2014/09
26.	その他	Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C. 2013/12
27.	その他	内視鏡的胆膵菅ドレナージのすべて悪性胆管閉塞に対する経皮経肝胆管ドレナージ-適応と選択基準,手技と管理- 2012/03
28.	原著(症例報告除く)	経皮的ラジオ波熱焼灼療法後に急速な肝外発育型の再発進展を来した肝細胞癌の1例 2005
5件表示
全件表示(28件)